New CMS TCET Rule Likely Won’t Hasten Medicare Coverage of Breakthrough Devices
Recently proposed rule seems too stringent to reduce the lag between FDA approval and Medicare coverage.
Recently proposed rule seems too stringent to reduce the lag between FDA approval and Medicare coverage.
From - National Intelligence Report
On Oct. 2, CMS proposed revisions to rules for appealing adverse Medicare claim determinations (Proposed Rules). The goal is to speed the process that…
From - National Intelligence Report
Lying to a Medicare auditor or otherwise obstructing a Medicare audit is a crime that can get you jailed…
From - National Intelligence Report
CMS recently issued its annual proposed rule on 2019 Medicare Part B reimbursement. For many labs, the number one concern is…
From - Diagnostic Testing & Emerging Technologies
After decades of resistance, CMS is giving serious indications of its willingness to entertain changes to relieve the…
From - National Intelligence Report
After decades of complaining about the Stark Law, the lab industry may now have an actual opportunity to secure meaningful relief…
By Sean McSweeney bio
In a press release on May 30, 2017, the Centers for Medicare & Medicaid Services (CMS) commented regarding their fraud prevention initiative program and their planned changes regarding…
From - National Intelligence Report
Although the 2018 market-based Clinical Laboratory Fee Schedule (CLFS) is officially in effect, implementation of the new PAMA Part B payment rules for lab tests remains…